Madia Lozupone MD, PhD

Dr. Madia Lozupone is a clinical researcher of Psychiatric Unit, Department of Mental Health Bari, Italy. From 2012, immediately after training, she was involved as psychiatrist in the PRIN2009E4RM4Z (the GreatAGE Study), a population-based study of South-East Italy, at IRCCS De Bellis in Castellana Grotte (Apulia). In October 2017 she achieved the title of PhD in Neurosciences and Translational Medicine at University of Bari Aldo Moro, Italy with the thesis entitled “Late-Life Depression: il contributo degli studi di popolazione. Metodologie di assessment, studio delle frequenze e dei determinanti”. She's actually pursuing a specific interest in old age psychiatry’s epidemiological study. The purpose of the psychiatric assessment of the GreatAGE Study “Impact of central and peripheral auditory dysfunctions on risk of onset of subjective cognitive impairment, mild cognitive impairment, dementia, Alzheimer's disease, vascular dementia and late onset depression”, was to investigate determinants, correlates and therapy adherence of common psychiatric disorders in the older age, particularly Late-life Depression. It involves the Neurology Unit, the Geriatric Unit, the Otolaryngology Unit and the Psychiatric Unit of University of Bari Aldo Moro and takes place in the Laboratory of Epidemiology and Biostatistics of the Istituto di Ricerca e Cura a Carattere Scientifico “S. De Bellis”, Health Technology Assessment and Digital Health Unit (Ageing Project Apulia Region). The study conducted from Dr. Lozupone in the psychiatric area has been focused on depressive disorders, particularly on late-life depression, defined as depression occurring in adults aged 65 years and over. Anxiety disorders, psychosis, and adjustment disorders were also studied. She is the author of several scientific papers published in international relevant journals in the field of geriatric psychiatry. From 2015 Dr Lozupone took part in the Board of Old Age psychiatry in the European Congress of Psychiatry. Dr. Lozupone's past remarkable contribution to the European Congress of Psychiatry were respectively in 2014 (free oral communication titled The GreatAGE Study: prevalence of late onset depression in elderly rural community of Castellana Grotte (Italy); in 2015 (e- Poster oral presentation titled Prevalence of anxiety disorders and comorbid affective disorders in the elderly of Castellana Grotte (Italy) in 2016 (free oral communication titled Validity of the Geriatric Depression Scale-30 against the gold standard diagnosis of depression in older age: The GreatAGE Study). The participation to EPA 2017 was in order to present others data about swallowing disorders in the elderly with psychiatric disorders and about the variables that influence elderly depression diagnosis. Lastly, at EPA 2019 two works about suicide ideation in the elderly and hearing impairment and Late-life Depression association were also presented (free oral communication titled “The association between age-related hearing loss, speech discrimination and late-life depressive disorders: results from the greaAGE study”). Another field of interest pursued from 2015 is the analysis of genetic polymorphisms, adverse drug reactions and targeted treatment of revolving door patients with psychiatric illnesses and specifically the pharmacogenetics of Cytochrome 2D6.